In general, incomplete surgical resection, large preoperative tumour size (>4 cm), midline-crossing tumours, and adverse tissue molecular characteristics (e.g., wild-type IDH and 1p/19q deficiency) are correlated with poorer prognosis [11,26]. This evidence concerns the gene IDH1 and neoplasm.